{"title":"Dietary Inflammatory Potential and the Risk of Neurodegenerative Diseases in Adults.","authors":"S. Kheirouri, M. Alizadeh","doi":"10.1093/epirev/mxz005","DOIUrl":"https://doi.org/10.1093/epirev/mxz005","url":null,"abstract":"Nutrition and diet have been suggested to induce or inhibit the risk of several neurodegenerative diseases and cognitive performance. This systematic review was developed to derive the relationship between inflammatory capacity of a diet and the risk of incidence of neurodegenerative diseases. Databases including PubMed, Google Scholar, ScienceDirect, and Scopus, as well as Google site were searched for any year until June 2018. Original, full text, and English language articles with human participants which investigated the link between dietary inflammatory potential and the risk of development of neurodegenerative diseases were included. Duplicated and irrelevant studies were removed and data were drawn out by critical analyzing of the articles. Initially, 457 articles were collected by the searching method, of which 196 studies remained after removing of duplicates. Fourteen articles were screened and known relevant to scope of the study. After critical analyzing, 10 articles were included in the final review. All the studies, except one reported that higher dietary inflammatory index (DII) was related to higher risk of developing neurodegenerative diseases symptoms including memory and cognition decline and Multiple Sclerosis. Of three studies, two indicated that DII positively correlated with circulating inflammatory markers. Low literacy, unhealthy life style, individuals' nutritional status were the factors that involved in intake of a diet with inflammatory potential. The findings enhance confidence that DII is an appropriate tool measure of dietary inflammatory potential and validate the role of diets with inflammatory potential in the pathophysiology of neurodegenerative diseases. DII may possibly be correlated with circulating inflammatory markers.","PeriodicalId":50510,"journal":{"name":"Epidemiologic Reviews","volume":" ","pages":""},"PeriodicalIF":5.5,"publicationDate":"2019-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/epirev/mxz005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46053183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
William Chi Wai Wong, Stephanie Tsz Hei Lau, Edmond Pui Hang Choi, J. Tucker, C. Fairley, J. Saunders
{"title":"A Systematic Literature Review of Reviews on the Effectiveness of Chlamydia Screening.","authors":"William Chi Wai Wong, Stephanie Tsz Hei Lau, Edmond Pui Hang Choi, J. Tucker, C. Fairley, J. Saunders","doi":"10.1093/EPIREV/MXZ007","DOIUrl":"https://doi.org/10.1093/EPIREV/MXZ007","url":null,"abstract":"Chlamydia trachomatis is the most common bacterial sexually transmitted infection, causing significant morbidity and economic burden. Strategies like national screening programs or hometesting kits were introduced in some developed countries, yet their effectiveness remains controversial. This systematic review examined reviews of chlamydia screening interventions to assess their effectiveness and the elements that contribute to their success to guide public policy and future research. The review assessed English material published after year 2000 in PubMed, Cochrane Library, the British Nursing Index, Medical Database, and Sociological Abstract, in addition to World Health Organization Global Health Sector Strategies, the European Center for Disease Prevention and Control guidelines, and PROSPERO. Systematic reviews that focused on chlamydia screening interventions were included. Using the socio-ecological model, we examined the levels of interventions that may affect the uptake of chlamydia screening. 19 systematic reviews were included. Self-collection in home-testing kits significantly increased screening among females 14-50 years of age. At the organizational level, using electronic health records and not creating additional costs facilitated testing. At the community level, outreach interventions in community/parent centers and homeless shelters reached high screening rates. At the policy level, interventions with educational and advisory elements could result in significant improvements in screening rates.","PeriodicalId":50510,"journal":{"name":"Epidemiologic Reviews","volume":" ","pages":""},"PeriodicalIF":5.5,"publicationDate":"2019-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/EPIREV/MXZ007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43456011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Post-Exposure Effects of Vaccines on Infectious Diseases.","authors":"Tara Gallagher, M. Lipsitch","doi":"10.1101/19001396","DOIUrl":"https://doi.org/10.1101/19001396","url":null,"abstract":"Many available vaccines have demonstrated post-exposure effectiveness, but no published systematic reviews have synthesized these findings. We searched the PubMed database for clinical trials and observational human studies concerning the post-exposure vaccination effects, targeting infections with Food and Drug Administration licensed vaccine plus dengue, hepatitis E, malaria, and tick borne encephalitis, which have licensed vaccines outside of the U.S. Studies concerning animal models, serologic testing, and pipeline vaccines were excluded. Eligible studies were evaluated by definition of exposure, and their attempt at distinguishing pre- and post-exposure effects was rated on a scale of 1-4. We screened 4518 articles and ultimately identified 14 clinical trials and 31 observational studies for this review, amounting to 45 eligible articles spanning 7 of the 28 vaccine-preventable diseases. For secondary attack rate, this body of evidence found the following medians for post-exposure vaccination effectiveness: hepatitis A: 85% (IQR: 28; 5 sources), hepatitis B: 85% (IQR: 22; 5 sources), measles: 83% (IQR: 21; 8 sources), varicella: 67% (IQR: 48; 9 sources), smallpox: 45% (IQR: 39; 4 sources), and mumps: 38% (IQR: 7; 2 sources). For case fatality proportions resulting from rabies and smallpox, the vaccine efficacies had medians of 100% (IQR: 0; 6 sources) and 63% (IQR: 50; 8 sources) postexposure. Although mainly used for preventive measures, many available vaccines can modify or preclude disease if administered after exposure. This post-exposure effectiveness could be important to consider during vaccine trials and while developing new vaccines.","PeriodicalId":50510,"journal":{"name":"Epidemiologic Reviews","volume":" ","pages":""},"PeriodicalIF":5.5,"publicationDate":"2019-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44370171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Review of Coccidioidomycosis in California: Exploring the Intersection of Land-use, Population Movement, and Climate Change.","authors":"Dharshani L. Pearson, Keita Ebisu, X. Wu, R. Basu","doi":"10.1093/epirev/mxz004","DOIUrl":"https://doi.org/10.1093/epirev/mxz004","url":null,"abstract":"California has seen a surge in coccidioidomycosis (Valley fever), a disease spread by the Coccidioides Immitis fungus found in soil throughout the state, particularly in the San Joaquin Valley. In this paper, we reviewed epidemiologic studies examining outbreak and sporadic cases of coccidioidomycosis and considered their possible relationship to environmental conditions, particularly the state's growing aridity, drought and wildfire conditions. Most of the studies we reviewed pertained to cases occupationally-acquired in construction, military, archeological and correctional institutional settings where workers faced exposure to dust in Coccidioides Immitis-endemic areas. A few reviewed outbreaks in the general population related to dust exposure from natural disasters, including an earthquake-associated landslide and a dust storm that carried particles long distances from endemic areas. Although many of California's coccidioidomycosis outbreaks have been occupationally-related, changing demographics and new, immunologically-naive populations in dry, endemic areas could expose the general population to Coccidioides Immitis spores. Given the high rate of infection among largely healthy workers, the general population, comprised of some elderly and immunocompromised individuals, could face additional risk. With climate-related events like drought and wildfires also increasing in endemic areas, future research is needed to address the possible associations between these phenomena and coccidioidomycosis outbreaks.","PeriodicalId":50510,"journal":{"name":"Epidemiologic Reviews","volume":" ","pages":""},"PeriodicalIF":5.5,"publicationDate":"2019-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/epirev/mxz004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49635585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fujiao Duan, Chunhua Song, Jintao Zhang, Peng Wang, H. Ye, L. Dai, Jianying Zhang, Kaijuan Wang
{"title":"Evaluation of the epidemiological efficacy of eradicating Helicobacter pylori on development of gastric cancer.","authors":"Fujiao Duan, Chunhua Song, Jintao Zhang, Peng Wang, H. Ye, L. Dai, Jianying Zhang, Kaijuan Wang","doi":"10.1093/epirev/mxz006","DOIUrl":"https://doi.org/10.1093/epirev/mxz006","url":null,"abstract":"Eradication of Helicobacter pylori (H. pylori) colonization has been reported to affect the progression of gastric cancer. A comprehensive literature search was performed from 1997 to 2017 through the electronic database. All randomized controlled trials (RCT) and non-randomized controlled trials (non-RCT) evaluated the effect of H. pylori eradication on development of gastric cancer. Four RCTs and nine non-RCTs were included, with a total of 40,740 participants (321,269 person-years). Overall, H. pylori eradication therapy was associated with a significantly reduced the risk of gastric cancer (Incidence rate ratio, IRR = 0.52, 95% CI: 0.41, 0.65). Results of mixed-effect Poisson regression meta-analysis were similar with traditional meta-analyses. In stratified analyses, the IRRs were 0.59 (95% CI: 0.41, 0.86) in RCTs and 0.48 (95% CI: 0.36, 0.64) in non-RCTs. The IRRs were 0.45 (95% CI: 0.34, 0.61) in patients and 0.63 (95% CI: 0.44, 0.90) in population. Moreover, the relative risk reduction was approximately 77% on the development of non-cardiac gastric cancer for H. pylori eradication therapy in China. Attributable risk percentage and population attributable risk percentage for Chinese patients were 77.08% and 75.33% and Japanese patients were 57.80% and 45.99%. In conclusion, H. pylori eradication therapy reduces the risk of developing non-cardiac gastric cancer, the findings indicate the importance of early intervention of H. pylori eradication therapy from the perspective of epidemiology.","PeriodicalId":50510,"journal":{"name":"Epidemiologic Reviews","volume":" ","pages":""},"PeriodicalIF":5.5,"publicationDate":"2019-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/epirev/mxz006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46129268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rodrigo Macedo Couto, Otavio T Ranzani, Eliseu Alves Waldman
{"title":"Zoonotic Tuberculosis in Humans: Control, Surveillance, and the One Health Approach.","authors":"Rodrigo Macedo Couto, Otavio T Ranzani, Eliseu Alves Waldman","doi":"10.1093/epirev/mxz002","DOIUrl":"https://doi.org/10.1093/epirev/mxz002","url":null,"abstract":"<p><p>Zoonotic tuberculosis is a reemerging infectious disease in high-income countries and a neglected one in low- and middle-income countries. Despite major advances in its control as a result of milk pasteurization, its global burden is unknown, especially due the lack of surveillance data. Additionally, very little is known about control strategies. The purpose of this review was to contextualize the current knowledge about the epidemiology of zoonotic tuberculosis and to describe the available evidence regarding surveillance and control strategies in high-, middle-, and low-income countries. We conducted this review enriched by a One Health perspective, encompassing its inherent multifaceted characteristics. We found that the burden of zoonotic tuberculosis is likely to be underreported worldwide, with higher incidence in low-income countries, where the surveillance systems are even more fragile. Together with the lack of specific political commitment, surveillance data is affected by lack of a case definition and limitations of diagnostic methods. Control measures were dependent on risk factors and varied greatly between countries. This review supports the claim that a One Health approach is the most valuable concept to build capable surveillance systems, resulting in effective control measures. The disease characteristics and suggestions to implement surveillance and control programs are discussed.</p>","PeriodicalId":50510,"journal":{"name":"Epidemiologic Reviews","volume":"41 1","pages":"130-144"},"PeriodicalIF":5.5,"publicationDate":"2019-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/epirev/mxz002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37836876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Heidi E Brown, Leslie K Dennis, Priscilla Lauro, Purva Jain, Erin Pelley, Eyal Oren
{"title":"Emerging Evidence for Infectious Causes of Cancer in the United States.","authors":"Heidi E Brown, Leslie K Dennis, Priscilla Lauro, Purva Jain, Erin Pelley, Eyal Oren","doi":"10.1093/epirev/mxz003","DOIUrl":"https://doi.org/10.1093/epirev/mxz003","url":null,"abstract":"<p><p>Worldwide, infectious agents currently contribute to an estimated 15% of new cancer cases. Most of these (92%, or 2 million new cancer cases) are attributable to 4 infectious agents: Helicobacter pylori, human papillomavirus, and hepatitis B and C viruses. A better understanding of how infectious agents relate to the US cancer burden may assist new diagnostic and treatment efforts. We review US-specific crude mortality rates from infection-associated cancers and describe temporal and spatial trends since 1999. We review the US-specific evidence for infection-cancer associations by reporting available estimates for attributable fractions for the infection-cancer associations. Death due to cancers with established infectious associations varies geographically, but estimates for the US attributable fraction are limited to a few observational studies. To describe the burden of infection-associated cancer in the United States, additional observational studies are necessary to estimate the prevalence of infection nationally and within subpopulations. As infectious associations emerge to explain cancer etiologies, new opportunities and challenges to reducing the burden arise. Improved estimates for the United States would help target interventions to higher-risk subpopulations.</p>","PeriodicalId":50510,"journal":{"name":"Epidemiologic Reviews","volume":"41 1","pages":"82-96"},"PeriodicalIF":5.5,"publicationDate":"2019-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/epirev/mxz003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37836877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Advances in Data Driven Responses to Preventing Spread of Antibiotic Resistance across Healthcare Settings.","authors":"S. Fridkin","doi":"10.1093/epirev/mxz010","DOIUrl":"https://doi.org/10.1093/epirev/mxz010","url":null,"abstract":"Among the most urgent and serious antibiotic resistant threats to public health, seven are bacteria predominately acquired during health care delivery. There is an emerging field of healthcare epidemiology focused on preventing healthcare-associated infections with antibiotic resistant bacteria incorporating data from patient transfers or patient movements both within and between facilities; this analytic field is being used to help public health professionals identify best opportunities for prevention. Different analytic approaches drawing on uses of big data is being explored to help target the use of limited public health resources, leverage expertise, and enact effective policy to maximize an impact on a population-level health. This paper will summarize recent advances in data driven responses to preventing spread of antibiotic resistance across healthcare settings: leveraging big data for machine learning, integration or advances in tracking patient movement, and highlighting the value of coordinating response across institutions within a region.","PeriodicalId":50510,"journal":{"name":"Epidemiologic Reviews","volume":" ","pages":""},"PeriodicalIF":5.5,"publicationDate":"2019-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/epirev/mxz010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48741016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Many Faces of Emerging and Re-emerging Infectious Disease.","authors":"J. Lessler, W. Orenstein","doi":"10.1093/epirev/mxz011","DOIUrl":"https://doi.org/10.1093/epirev/mxz011","url":null,"abstract":"The emergence of disease threats can take many forms, from the adaptation of a traditionally zoonotic pathogen for efficient spread in humans, to the development of antibiotic resistance in well-known pathogens, to the creation of new niches for established disease through social and societal changes. In this commentary, the authors explore these various facets of disease emergence through the lens of the papers included in this issue of Epidemiologic Reviews. The authors explore multiple aspects of emergence, and the ways in which emergent pathogens can be controlled with the limited tools available. In doing so they put the papers in this issue in the context of the broader research agenda around understanding and combatting emergent pathogens.","PeriodicalId":50510,"journal":{"name":"Epidemiologic Reviews","volume":" ","pages":""},"PeriodicalIF":5.5,"publicationDate":"2019-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/epirev/mxz011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47360726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Awofisayo-Okuyelu, J. Brainard, I. Hall, N. McCarthy
{"title":"Incubation Period of Shiga Toxin–Producing Escherichia coli","authors":"A. Awofisayo-Okuyelu, J. Brainard, I. Hall, N. McCarthy","doi":"10.1093/epirev/mxz001","DOIUrl":"https://doi.org/10.1093/epirev/mxz001","url":null,"abstract":"Abstract Shiga toxin–producing Escherichia coli are pathogenic bacteria found in the gastrointestinal tract of humans. Severe infections could lead to life-threatening complications, especially in young children and the elderly. Understanding the distribution of the incubation period, which is currently inconsistent and ambiguous, can help in controlling the burden of disease. We conducted a systematic review of outbreak investigation reports, extracted individual incubation data and summary estimates, tested for heterogeneity, classified studies into subgroups with limited heterogeneity, and undertook a meta-analysis to identify factors that may contribute to the distribution of the pathogen’s incubation period. Twenty-eight studies were identified for inclusion in the review (1 of which included information on 2 outbreaks), and the resulting I2 value was 77%, indicating high heterogeneity. Studies were classified into 5 subgroups, with the mean incubation period ranging from 3.5 to 8.1 days. The length of the incubation period increased with patient age and decreased by 7.2 hours with every 10% increase in attack rate.","PeriodicalId":50510,"journal":{"name":"Epidemiologic Reviews","volume":" ","pages":""},"PeriodicalIF":5.5,"publicationDate":"2019-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/epirev/mxz001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49164372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}